Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Advanced cancer patient wnowledge of and attitudes towards tumor molecular profiling


Limited research has indicated that despite their overwhelming interest in tumor molecular profiling (MP),(1) cancer patients have poor knowledge about MP. The current study aimed to investigate demographic and psychological predictors of knowledge and perceived importance of MP in an advanced cancer patient cohort. Eligible participants had advanced solid cancers of any histological type with sufficient accessible tissue for MP and were enrolled in the Molecular Screening and Therapeutics (MoST) Program. A questionnaire was completed by 1074 participants (91% response rate) after consent, prior to undergoing MP. Overall, participants had poor to moderate knowledge of MP, yet perceived MP to have high importance. Higher education, speaking English at home, and greater satisfaction with the decision to undergo MP were associated with higher knowledge scores. More negative attitudes towards uncertainty, greater self-efficacy to cope with results, and lower perceived likelihood of cancer progression were associated with greater perceived importance of MP. Less educated participants and those who do not speak English at home will need clear explanations, visual aids and ample opportunity to ask questions about MP at the time of their decision-making. Clinicians also need to consider psychological factors relevant to patients' decision to pursue MP. Given the increased awareness of and demand for cancer genomic information and the rapidly changing nature of the actionability of MP, these findings will help inform an important ongoing debate on how to facilitate ethical and informed consent and manage patient expectations about personalized treatments.

Type Journal
ISBN 1936-5233 (Print) 1936-5233 (Linking)
Authors Davies, G.; Butow, P.; Napier, C. E.; Bartley, N.; Juraskova, I.; Meiser, B.; Ballinger, M. L.; Thomas, D. M.; Schlub, T. E.; Best, M. C.; members of the PiGeOn, Project.
Responsible Garvan Author Dr Mandy Ballinger
Publisher Name Translational Oncology
Published Date 2020-09-01
Published Volume 13
Published Issue 9
Published Pages 100799
Status Always Electronic
DOI 10.1016/j.tranon.2020.100799
URL link to publisher's version